Journal
NATURE COMMUNICATIONS
Volume 9, Issue -, Pages -Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-018-07309-4
Keywords
-
Categories
Funding
- Australian National Health and Medical Research Council [1043149, 1090236, 1016701, 1057742, 1059290, 1078763, 1078924, 1083077, 1113133, 1124737]
- Leukaemia & Lymphoma Society (SCOR grant) [7001-13]
- Australian Research Council [FT100100791]
- Cancer Council Victoria
- Australian Government IRISS
- Victorian State Government [OIS 9000220]
- Melbourne University
- Walter and Eliza Hall Institute of Medical Research
- Australian Cancer Research Foundation
- National Health and Medical Research Council of Australia [1078763, 1078924, 1059290, 1057742, 1124737, 1083077] Funding Source: NHMRC
- Australian Research Council [FT100100791] Funding Source: Australian Research Council
Ask authors/readers for more resources
Intrinsic apoptosis is critical to prevent tumor formation and is engaged by many anti-cancer agents to eliminate tumor cells. BAX and BAK, the two essential mediators of apoptosis, are thought to be regulated through similar mechanisms and act redundantly to drive apoptotic cell death. From an unbiased genome-wide CRISPR/Cas9 screen, we identified VDAC2 (voltage-dependent anion channel 2) as important for BAX, but not BAK, to function. Genetic deletion of VDAC2 abrogated the association of BAX and BAK with mitochondrial complexes containing VDAC1, VDAC2, and VDAC3, but only inhibited BAX apoptotic function. Deleting VDAC2 phenocopied the loss of BAX in impairing both the killing of tumor cells by anti-cancer agents and the ability to suppress tumor formation. Together, our studies show that efficient BAX-mediated apoptosis depends on VDAC2, and reveal a striking difference in how BAX and BAK are functionally impacted by their interactions with VDAC2.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available